Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370199 · ClinicalTrials.gov registry record · NA
Peripheral Blood Flow Responses to Electromagnetic Energy
A NA study of Exposure to Man-made Visible Light, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02370199: Recruiting NA study of Exposure to Man-made Visible Light, sponsored by University of Alabama at Birmingham.
NCT02370199 is a NA study of Exposure to Man-made Visible Light that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02370199, a NA study of Exposure to Man-made Visible Light, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates 670 nm energy in the form of red light to stimulate blood flow changes in healthy adults. All participants will receive red light to their leg. They will also receive a continuous infusion of Definity (octafluoropropane) ultrasound contrast.
Primary Outcome
Blood flow changes based on ultrasound imaging
Conditions Studied
Interventions
- DEVICE 670 nm light
- DRUG octafluropropane
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-11 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT02370199 shows while recruiting
NCT02370199 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Exposure to Man-made Visible Light appearing as the primary indexed condition, and to 2 interventions - of which 670 nm light is the first listed.
NCT02370199 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT02370199 about?
NCT02370199 is a clinical study titled "Peripheral Blood Flow Responses to Electromagnetic Energy". This study evaluates 670 nm energy in the form of red light to stimulate blood flow changes in healthy adults. All participants will receive red light to their leg. They will also receive a continuous infusion of Definity (octafluoropropane) ultrasound contrast.
What is the current status of trial NCT02370199?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2014-11. Estimated completion is 2027-12-31.
What conditions does trial NCT02370199 study?
This clinical trial studies the following conditions: Exposure to Man-made Visible Light.
What interventions are being tested in trial NCT02370199?
The interventions under investigation include: 670 nm light (DEVICE), octafluropropane (DRUG).
Who is sponsoring clinical trial NCT02370199?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02370199 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02370199's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia